PLRX vs TECH
Pliant Therapeutics Inc (PLRX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PLRX currently screens at market cap $77.3M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PLRX and TECH stock pages for the full models.
Not investment advice.